Xinyi Z.

Xinyi Z. has a diverse work experience in various industries. In 2014, they worked in research and development as a Peptide Engineering specialist at China Pharmaceutical University. From 2015 to 2016, Xinyi Z. worked at Merck Group in the field of HEOR and Real World Evidence. They then joined New York University as a Molecular Biology and Engineering Scientist from 2016 to 2018. In 2017, Xinyi Z. served as a Research Consultant - Life Science Strategy at Navigant, analyzing market resources strategies and conducting competitive landscape assessments. From 2018 to 2021, they co-founded and served as the CEO of EMW3, focusing on growth marketing craftsmanship and redefining marketing as a powerful engine for business growth. In 2020, Xinyi Z. transitioned to Hudson Holdings Group as the VP of Global Business Development. Currently, Xinyi Z. is working in Business Development and Marketing at Synbio Technologies since 2022.

Xinyi Z. holds a Master's degree in Biotechnology from New York University. Xinyi also has completed the Business Administration CORe program at Harvard Business School, with a focus on Finance, General. Xinyi Z. obtained their Bachelor's degree in Biopharmaceutical Technology from China Pharmaceutical University.